Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anastomotic Leak × Metronidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, B-Cell, Marginal Zone 4 Colorectal Neoplasms 4 Rectal Neoplasms 3 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1 Pilonidal Sinus 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

Water 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Serum Albumin, Human 1 Saline Solution 1 Neomycin 1 Metronidazole 1 Esophagectomy 1 Ciprofloxacin 1 Bioseal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡